MIR152 (microRNA 152) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: MIR152 (microRNA 152) Homo sapiens
Analyze
Symbol: MIR152
Name: microRNA 152
RGD ID: 1349588
HGNC Page HGNC:31538
Description: Enables mRNA 3'-UTR binding activity and mRNA base-pairing translational repressor activity. Involved in several processes, including negative regulation of gene expression; negative regulation of tumor necrosis factor-mediated signaling pathway; and negative regulation of vascular endothelial cell proliferation. Located in extracellular space and extracellular vesicle. Implicated in colorectal cancer; colorectal carcinoma; endometrial carcinoma; and stomach cancer. Biomarker of several diseases, including gastrointestinal system cancer (multiple); liver cirrhosis; lung cancer; reproductive organ cancer (multiple); and urinary bladder cancer.
Type: ncrna (Ensembl: miRNA)
RefSeq Status: PROVISIONAL
Previously known as: mir-152; MIRN152
RGD Orthologs
Mouse
Rat
Dog
Pig
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381748,037,161 - 48,037,247 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1748,037,161 - 48,037,247 (-)EnsemblGRCh38hg38GRCh38
GRCh371746,114,527 - 46,114,613 (-)NCBIGRCh37GRCh37hg19GRCh37
Celera1742,567,346 - 42,567,432 (-)NCBICelera
Cytogenetic Map17q21.32NCBI
HuRef1741,483,141 - 41,483,227 (-)NCBIHuRef
CHM1_11746,179,516 - 46,179,602 (-)NCBICHM1_1
T2T-CHM13v2.01748,898,973 - 48,899,059 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function

References

References - curated
# Reference Title Reference Citation
1. Evaluation of Plasma miR-21 and miR-152 as Diagnostic Biomarkers for Common Types of Human Cancers. Chen H, etal., J Cancer. 2016 Feb 5;7(5):490-9. doi: 10.7150/jca.12351. eCollection 2016.
2. [Circulating miR-152 helps early prediction of postoperative biochemical recurrence of prostate cancer]. Chen JF, etal., Zhonghua Nan Ke Xue. 2017 Jul;23(7):603-608.
3. Polymorphisms and haplotypes of the miR-148/152 family are associated with the risk and clinicopathological features of gastric cancer in a Northern Chinese population. Chen X, etal., Mutagenesis. 2014 Nov;29(6):401-7. doi: 10.1093/mutage/geu050. Epub 2014 Sep 26.
4. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. Chen Y, etal., J Gastrointest Surg. 2010 Jul;14(7):1170-9. doi: 10.1007/s11605-010-1202-2. Epub 2010 Apr 27.
5. MiR-152 influences osteoporosis through regulation of osteoblast differentiation by targeting RICTOR. Feng L, etal., Pharm Biol. 2019 Dec;57(1):586-594. doi: 10.1080/13880209.2019.1657153.
6. MicroRNA-152 attenuates neuroinflammation in intracerebral hemorrhage by inhibiting thioredoxin interacting protein (TXNIP)-mediated NLRP3 inflammasome activation. Hu L, etal., Int Immunopharmacol. 2020 Jan 23;80:106141. doi: 10.1016/j.intimp.2019.106141.
7. miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3. Li B, etal., Tumour Biol. 2016 Jan 28.
8. Downregulation of miR-152 contributes to the progression of liver fibrosis via targeting Gli3 in vivo and in vitro. Li L, etal., Exp Ther Med. 2019 Jul;18(1):425-434. doi: 10.3892/etm.2019.7595. Epub 2019 May 20.
9. MicroRNA‑152 inhibits cell proliferation, migration and invasion by directly targeting MAFB in nasopharyngeal carcinoma. Li Y, etal., Mol Med Rep. 2017 Feb;15(2):948-956. doi: 10.3892/mmr.2016.6059. Epub 2016 Dec 19.
10. MicroRNA-152 modulates the canonical Wnt pathway activation by targeting DNA methyltransferase 1 in arthritic rat model. Miao CG, etal., Biochimie. 2014 Nov;106:149-56. doi: 10.1016/j.biochi.2014.08.016. Epub 2014 Sep 4.
11. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach. Pavicic W, etal., Mol Med. 2011;17(7-8):726-35. doi: 10.2119/molmed.2010.00239. Epub 2011 Feb 9.
12. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
13. Potential role of circulating microRNAs as early markers of preeclampsia. Ura B, etal., Taiwan J Obstet Gynecol. 2014 Jun;53(2):232-4. doi: 10.1016/j.tjog.2014.03.001.
14. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma. Wang F, etal., Tumour Biol. 2016 Apr;37(4):4945-53. doi: 10.1007/s13277-015-4340-z. Epub 2015 Nov 3.
15. MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma. Wang Y, etal., Oncotarget. 2017 Apr 25;8(17):28125-28134. doi: 10.18632/oncotarget.15924.
16. Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer. Watahiki A, etal., Int J Mol Sci. 2013 Apr 10;14(4):7757-70. doi: 10.3390/ijms14047757.
17. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. Xu Q, etal., J Mol Cell Biol. 2013 Feb;5(1):3-13. doi: 10.1093/jmcb/mjs049. Epub 2012 Aug 29.
18. miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8. Yin T, etal., Pathol Res Pract. 2019 Jun;215(6):152406. doi: 10.1016/j.prp.2019.03.034. Epub 2019 Apr 1.
19. Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation. Yu F, etal., J Cell Mol Med. 2015 Nov;19(11):2617-32. doi: 10.1111/jcmm.12655. Epub 2015 Aug 10.
20. A novel regulatory circuit of miR‑152 and DNMT1 in human bladder cancer. Zhang H, etal., Oncol Rep. 2018 Sep;40(3):1803-1812. doi: 10.3892/or.2018.6553. Epub 2018 Jul 10.
21. MicroRNA-152 Acts as a Tumor Suppressor MicroRNA by Inhibiting Krüppel-Like Factor 5 in Human Cervical Cancer. Zhang H, etal., Oncol Res. 2019 Feb 21;27(3):335-340. doi: 10.3727/096504018X15252202178408. Epub 2018 Aug 21.
22. Correlation of MiR-152 expression with VEGF expression in placental tissue of preeclampsia rat and its influence on apoptosis of trophoblast cells. Zhang L, etal., Eur Rev Med Pharmacol Sci. 2019 May;23(9):3553-3560. doi: 10.26355/eurrev_201905_17776.
23. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152. Zhang S, etal., Dig Dis Sci. 2017 Nov;62(11):3050-3058. doi: 10.1007/s10620-017-4759-8. Epub 2017 Sep 18.
Additional References at PubMed
PMID:12007417   PMID:16381832   PMID:17604727   PMID:17616659   PMID:20158877   PMID:20574809   PMID:20578129   PMID:21037258   PMID:21868754   PMID:21971665   PMID:22095477   PMID:22295098  
PMID:22438923   PMID:22909061   PMID:23034410   PMID:23125218   PMID:23238588   PMID:23318422   PMID:23460133   PMID:23716670   PMID:23867826   PMID:24416131   PMID:24448385   PMID:24780186  
PMID:24813629   PMID:24998573   PMID:25004396   PMID:25095980   PMID:25119599   PMID:25190353   PMID:25218589   PMID:25228695   PMID:25311946   PMID:25501703   PMID:25578780   PMID:25703326  
PMID:25802486   PMID:25904302   PMID:25912229   PMID:26187665   PMID:26400224   PMID:26468017   PMID:26515145   PMID:26627200   PMID:26646931   PMID:26657500   PMID:26823738   PMID:26991832  
PMID:27015561   PMID:27383317   PMID:27461630   PMID:27469625   PMID:27475839   PMID:27588491   PMID:27840403   PMID:27900663   PMID:27922690   PMID:28063929   PMID:28247844   PMID:28258379  
PMID:28472596   PMID:28544374   PMID:28764788   PMID:28798470   PMID:28810933   PMID:28880997   PMID:28929922   PMID:28945992   PMID:28978904   PMID:29162853   PMID:29286064   PMID:29353204  
PMID:29442022   PMID:29508126   PMID:29599847   PMID:29670086   PMID:29703916   PMID:29845282   PMID:29990486   PMID:30076720   PMID:30106118   PMID:30451334   PMID:30470842   PMID:30478668  
PMID:30575920   PMID:30638178   PMID:30659641   PMID:30661902   PMID:30787934   PMID:31081143   PMID:31104329   PMID:31269585   PMID:31307184   PMID:31378893   PMID:31430452   PMID:31492194  
PMID:31533306   PMID:31607298   PMID:31609010   PMID:31615875   PMID:31646827   PMID:31712391   PMID:32056038   PMID:32150671   PMID:32227563   PMID:32337535   PMID:32408908   PMID:32513696  
PMID:32768498   PMID:32776748   PMID:32808542   PMID:32861793   PMID:32876927   PMID:33059275   PMID:33249973   PMID:33269380   PMID:33507312   PMID:33548980   PMID:33659051   PMID:33682607  
PMID:33712363   PMID:34165388   PMID:34374627   PMID:34418232   PMID:34689723   PMID:34778942   PMID:35236289   PMID:35314531   PMID:35345660   PMID:35523108   PMID:35950471   PMID:35996507  
PMID:36047706   PMID:36082713   PMID:36331285   PMID:37171551   PMID:37272598   PMID:37899376   PMID:38070277  


Genomics

Comparative Map Data
MIR152
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381748,037,161 - 48,037,247 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1748,037,161 - 48,037,247 (-)EnsemblGRCh38hg38GRCh38
GRCh371746,114,527 - 46,114,613 (-)NCBIGRCh37GRCh37hg19GRCh37
Celera1742,567,346 - 42,567,432 (-)NCBICelera
Cytogenetic Map17q21.32NCBI
HuRef1741,483,141 - 41,483,227 (-)NCBIHuRef
CHM1_11746,179,516 - 46,179,602 (-)NCBICHM1_1
T2T-CHM13v2.01748,898,973 - 48,899,059 (-)NCBIT2T-CHM13v2.0
Mir152
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391196,741,219 - 96,741,291 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1196,741,219 - 96,741,291 (+)EnsemblGRCm39 Ensembl
GRCm381196,850,393 - 96,850,465 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1196,850,393 - 96,850,465 (+)EnsemblGRCm38mm10GRCm38
MGSCv371196,711,707 - 96,711,779 (+)NCBIGRCm37MGSCv37mm9NCBIm37
Cytogenetic Map11DNCBI
cM Map1160.13NCBI
Mir152
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81082,329,383 - 82,329,467 (+)NCBIGRCr8
mRatBN7.21081,832,936 - 81,833,020 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1081,832,936 - 81,833,020 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1086,780,647 - 86,780,731 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01086,278,702 - 86,278,786 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01081,671,301 - 81,671,385 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01084,719,319 - 84,719,403 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1084,719,319 - 84,719,403 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01084,512,232 - 84,512,316 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera1080,594,606 - 80,594,690 (+)NCBICelera
Cytogenetic Map10q31NCBI
MIR152
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1924,335,161 - 24,335,219 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl924,335,146 - 24,335,225 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha923,800,932 - 23,800,990 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0925,128,568 - 25,128,626 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl925,128,553 - 25,128,632 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1923,898,331 - 23,898,389 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0924,158,972 - 24,159,030 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0924,286,093 - 24,286,151 (-)NCBIUU_Cfam_GSD_1.0
MIR152
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1224,292,251 - 24,292,336 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11224,292,249 - 24,292,328 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21224,289,536 - 24,289,615 (-)NCBISscrofa10.2Sscrofa10.2susScr3


Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 17q21.33-24.2(chr17:36449220-68170214)x3 copy number gain See cases [RCV000050957] Chr17:36449220..68170214 [GRCh38]
Chr17:48563237..65936105 [GRCh37]
Chr17:45918236..63677950 [NCBI36]
Chr17:17q21.33-24.2		 pathogenic
GRCh38/hg38 17q23.2-25.3(chr17:36449220-83086677)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052483]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052483]|See cases [RCV000052483] Chr17:36449220..83086677 [GRCh38]
Chr17:58617905..81044553 [GRCh37]
Chr17:55972687..78637842 [NCBI36]
Chr17:17q23.2-25.3		 pathogenic
GRCh38/hg38 17q21.31-21.33(chr17:44955325-49381173)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052480]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052480]|See cases [RCV000052480] Chr17:44955325..49381173 [GRCh38]
Chr17:43032693..47458535 [GRCh37]
Chr17:40388219..44813534 [NCBI36]
Chr17:17q21.31-21.33		 pathogenic
GRCh38/hg38 17q23.1-25.1(chr17:36449220-75053130)x3 copy number gain See cases [RCV000137437] Chr17:36449220..75053130 [GRCh38]
Chr17:57595736..73049225 [GRCh37]
Chr17:54950518..70560820 [NCBI36]
Chr17:17q23.1-25.1		 pathogenic
GRCh38/hg38 17q21.32-21.33(chr17:47986886-49329397)x1 copy number loss See cases [RCV000142900] Chr17:47986886..49329397 [GRCh38]
Chr17:46064252..47406759 [GRCh37]
Chr17:43419251..44761758 [NCBI36]
Chr17:17q21.32-21.33		 pathogenic
GRCh37/hg19 17q21.31-25.3(chr17:42580684-81085615)x3 copy number gain See cases [RCV000447823] Chr17:42580684..81085615 [GRCh37]
Chr17:17q21.31-25.3		 pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938) copy number gain See cases [RCV000511439] Chr17:526..81041938 [GRCh37]
Chr17:17p13.3-q25.3		 pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938)x3 copy number gain See cases [RCV000512441] Chr17:526..81041938 [GRCh37]
Chr17:17p13.3-q25.3		 pathogenic
GRCh37/hg19 17q21.32(chr17:45884442-46124946)x3 copy number gain not provided [RCV000683940] Chr17:45884442..46124946 [GRCh37]
Chr17:17q21.32		 uncertain significance
GRCh37/hg19 17p13.3-q25.3(chr17:12344-81057996)x3 copy number gain not provided [RCV000739325] Chr17:12344..81057996 [GRCh37]
Chr17:17p13.3-q25.3		 pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:8547-81060040)x3 copy number gain not provided [RCV000739324] Chr17:8547..81060040 [GRCh37]
Chr17:17p13.3-q25.3		 pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:7214-81058310)x3 copy number gain not provided [RCV000739320] Chr17:7214..81058310 [GRCh37]
Chr17:17p13.3-q25.3		 pathogenic
GRCh37/hg19 17q21.32(chr17:44949883-46507482) copy number gain PNPO-related disorders [RCV003236737] Chr17:44949883..46507482 [GRCh37]
Chr17:17q21.32		 likely pathogenic
miRNA Target Status

Confirmed Targets
Gene TargetMature miRNAMethod NameResult TypeData TypeSupport TypePMID
HLA-Ghsa-miR-152-3pMirtarbaseexternal_infoLuciferase reporter assayFunctional MTI17847008
DNMT1hsa-miR-152-3pMirtarbaseexternal_infoLuciferase reporter assayFunctional MTI20146264
DNMT1hsa-miR-152-3pMirtarbaseexternal_infoLuciferase reporter assay//Microarray//qRT-PCR//WeFunctional MTI20841484
DNMT1hsa-miR-152-3pMirtarbaseexternal_infoLuciferase reporter assay//qRT-PCR//Western blot//Functional MTI20578129
DNMT1hsa-miR-152-3pMirtarbaseexternal_infoImmunoblot//Immunoprecipitaion//Luciferase reporteFunctional MTI23125218
IRS1hsa-miR-152-3pMirtarbaseexternal_infoLuciferase reporter assay//Western blotFunctional MTI22935141
TGFAhsa-miR-152-3pMirtarbaseexternal_infoLuciferase reporter assayFunctional MTI23460133
SETDB1hsa-miR-152-3pMirtarbaseexternal_infoCLASHFunctional MTI (Weak)23622248
TGFAhsa-miR-152-3pOncomiRDBexternal_infoNANA23460133
DNMT1hsa-miR-152-3pOncomiRDBexternal_infoNANA23318422
DNMT1hsa-miR-152-3pOncomiRDBexternal_infoNANA22935141
E2F3hsa-miR-152-3pOncomiRDBexternal_infoNANA21868754
DNMT1hsa-miR-152-3pOncomiRDBexternal_infoNANA20841484
DNMT1hsa-miR-152-3pOncomiRDBexternal_infoNANA20578129
DNMT1hsa-miR-152-3pOncomiRDBexternal_infoNANA20146264
DNMT1hsa-miR-152-5pTarbaseexternal_infoReporter GenePOSITIVE
DNMT1hsa-miR-152-5pTarbaseexternal_infoqPCRPOSITIVE
DNMT1hsa-miR-152-5pTarbaseexternal_infoWesternblitPOSITIVE
DNMT1hsa-miR-152-5pMirecordsexternal_infoNANA20146264

Predicted Targets
Summary Value
Count of predictions:31080
Count of gene targets:11886
Count of transcripts:24359
Interacting mature miRNAs:hsa-miR-152-3p, hsa-miR-152-5p
Prediction methods:Microtar, Miranda, Pita, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage entire extraembryonic component
High
Medium
Low 26 28 46 18 91 17 70 36 65 35 75 83 3 9 21 1
Below cutoff 45 32 21 7 35 5 61 48 39 9 23 34 3 15 36 1

Sequence


Reference Sequences
RefSeq Acc Id: ENST00000385212
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl1748,037,161 - 48,037,247 (-)Ensembl
RefSeq Acc Id: NR_029687
RefSeq Status: PROVISIONAL
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381748,037,161 - 48,037,247 (-)NCBI
GRCh371746,114,527 - 46,114,613 (-)RGD
Celera1742,567,346 - 42,567,432 (-)RGD
HuRef1741,483,141 - 41,483,227 (-)RGD
CHM1_11746,179,516 - 46,179,602 (-)NCBI
T2T-CHM13v2.01748,898,973 - 48,899,059 (-)NCBI
Sequence:

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:31538 AgrOrtholog
COSMIC MIR152 COSMIC
Ensembl Genes ENSG00000207947 Ensembl, ENTREZGENE
Ensembl Transcript ENST00000385212 ENTREZGENE
GTEx ENSG00000207947 GTEx
HGNC ID HGNC:31538 ENTREZGENE
Human Proteome Map MIR152 Human Proteome Map
miRBase MI0000462 ENTREZGENE
NCBI Gene 406943 ENTREZGENE
OMIM 613788 OMIM
PharmGKB PA164722508 PharmGKB
RNAcentral URS000000C73C RNACentral
  URS00003AFD9B RNACentral
  URS00006A0932 RNACentral


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2011-07-27 MIR152  microRNA 152  MIRN152  microRNA 152  Symbol and/or name change 5135510 APPROVED